HIV-associated psoriasis is associated with significant morbidity and mortality and can be an
extremely challenging disease to manage in patients with baseline underlying …

Human immunodeficiency virus (HIV) prevalence is increasing worldwide as people on
antiretroviral therapy are living longer. These patients are often susceptible to debilitating …

BACKGROUND: Patients with psoriasis and HIV infection often present with more severe
and treatment-refractory cutaneous disease. In addition, many of these patients have …

Standard treatments for moderate-to-severe, refractory psoriatic disease generally involve
immunosuppressant medications, which can complicate treatment in patients with …

Cutaneous diseases such as psoriasis are often the first disease manifestations in HIV+
patients, with greater severity corresponding to a weaker immune system. Despite its …

HIV has long been associated with a number of inflammatory, infectious, and neoplastic skin
conditions. In the era of anti-retroviral therapy, we have discovered even more about the …

Psoriasis is a chronic papulosquamous skin disease that is thought to be a T-cell-mediated
autoimmune disorder of keratinocyte proliferation. The association between psoriasis and …

Background: The management of HIV-positive patients with psoriasis is controversial and
limited to individual cases or short series of patients. Objectives: To evaluate the safety and …

Non-AIDS morbidity and mortality are increasingly common in the HIV-infected population.
Chronic inflammation and immunosenescence result in early onset of conditions associated …